SG147453A1 - Pharmaceutical aerosol compositions - Google Patents

Pharmaceutical aerosol compositions

Info

Publication number
SG147453A1
SG147453A1 SG200807804-0A SG2008078040A SG147453A1 SG 147453 A1 SG147453 A1 SG 147453A1 SG 2008078040 A SG2008078040 A SG 2008078040A SG 147453 A1 SG147453 A1 SG 147453A1
Authority
SG
Singapore
Prior art keywords
aerosol compositions
pharmaceutical aerosol
pharmaceutical
compositions
aerosol
Prior art date
Application number
SG200807804-0A
Other languages
English (en)
Inventor
Julianne Berry
Jill K Sherwood
Saeed Chaudhry
Joel A Sequeira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of SG147453A1 publication Critical patent/SG147453A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG200807804-0A 2003-10-20 2004-10-18 Pharmaceutical aerosol compositions SG147453A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51272503P 2003-10-20 2003-10-20

Publications (1)

Publication Number Publication Date
SG147453A1 true SG147453A1 (en) 2008-11-28

Family

ID=34549219

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200807804-0A SG147453A1 (en) 2003-10-20 2004-10-18 Pharmaceutical aerosol compositions

Country Status (13)

Country Link
US (2) US20050136009A1 (fr)
EP (1) EP1684717A2 (fr)
JP (2) JP2007509147A (fr)
KR (1) KR20060106823A (fr)
CN (1) CN1870976A (fr)
AU (1) AU2004285447A1 (fr)
BR (1) BRPI0415707A (fr)
CA (1) CA2542530A1 (fr)
MX (1) MXPA06004331A (fr)
NO (1) NO20062279L (fr)
SG (1) SG147453A1 (fr)
WO (1) WO2005041931A2 (fr)
ZA (1) ZA200603121B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1542904E (pt) * 2002-08-27 2008-03-24 Schering Corp Processo para produzir formulações para inaladores doseadores
PL1711164T3 (pl) * 2004-01-21 2010-09-30 Merck Sharp & Dohme Sposób leczenia ostrego zapalenia zatok przynosowych
US20070203104A1 (en) * 2006-02-09 2007-08-30 Chaudhry Saeed M Pharmaceutical Formulations
MX2009008572A (es) * 2007-02-09 2009-10-19 Schering Corp Aerosoles estables con farmaco de grado farmaceutico.
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (fr) * 1956-03-21 1900-01-01
US2885427A (en) * 1956-11-15 1959-05-05 Dow Chemical Co Fluorination of trichloroethylene
US3320125A (en) * 1964-04-28 1967-05-16 Merck & Co Inc Inhalation aerosol composition
US3261748A (en) * 1964-07-17 1966-07-19 Dow Chemical Co 1,1,1,2-tetrafluoroethane anesthetic
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
US4129603A (en) * 1978-02-07 1978-12-12 Imperial Chemical Industries Limited Manufacture of halogenated compounds
US4311863A (en) * 1980-06-11 1982-01-19 E. I. Du Pont De Nemours & Company Process for the manufacture of 1,1,1,2-tetrafluoroethane
US4851595A (en) * 1987-07-07 1989-07-25 E. I. Du Pont De Nemours And Company Liquid phase halogen exchange process for the manufacture of 1,1,1,2-tetrafluoroethane
US4967024A (en) * 1988-06-23 1990-10-30 E. I. Du Pont De Nemours And Company Catalyzed hydrofluorination process
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US6006745A (en) * 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
ES2158910T3 (es) * 1991-06-10 2001-09-16 Schering Corp Formulaciones en aerosol sin clorofluorocarbonos.
EP0587790B2 (fr) * 1991-06-10 2000-03-08 Schering Corporation Compositions aerosol sans chlorofluorocarbones
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US7101534B1 (en) * 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
EP0617713A1 (fr) * 1991-12-18 1994-10-05 Schering Corporation Procede destine a eliminer les additifs residuels d'articles en elastomere
US7105152B1 (en) * 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
DE69233319T2 (de) * 1991-12-18 2005-02-17 Minnesota Mining & Manufacturing Company, St. Paul Aerosolzusammensetzungen für Arzneimittelsuspensionen
US5202110A (en) * 1992-01-22 1993-04-13 Virginia Commonwealth University Formulations for delivery of beclomethasone diproprionate by metered dose inhalers containing no chlorofluorocarbon propellants
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
GB2314336A (en) * 1996-06-18 1997-12-24 Bespak Plc Method of cleaning or purifying elastomers and elastomeric articles which are intended for medical or pharmaceutical use
DE69705628T2 (de) * 1996-08-29 2002-05-08 Schering Corp., Kenilworth Chlorfluorkohlenwasserstoff freie aerosol-arzneizubereitungen enthaltend mometasonfuroat
US6068832A (en) * 1996-08-29 2000-05-30 Schering Corporation Chlorofluorocarbon-free mometasone furoate aerosol formulations
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
US20020076382A1 (en) * 2000-08-04 2002-06-20 Kaplan Leonard W. Formulations of mometasone and a bronchodilator for pulmonary administration
EP1241113A1 (fr) * 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhalateur avec des moyens pour améliorer la stabilité chimique des solutions d'aerosol médicinales qu'il contient
US20030148030A1 (en) * 2001-06-12 2003-08-07 Vernon Paul M. Barrier coatings for elastomeric materials
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
US20050129620A1 (en) * 2001-12-07 2005-06-16 Clark Verna L. Metering valve and pharmaceutical metered dose inhaler and methods thereof
CA2495689A1 (fr) * 2002-08-23 2004-03-04 Schering Corporation Compositions pharmaceutiques
PT1542904E (pt) * 2002-08-27 2008-03-24 Schering Corp Processo para produzir formulações para inaladores doseadores
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products

Also Published As

Publication number Publication date
US20080064674A1 (en) 2008-03-13
JP2008024721A (ja) 2008-02-07
WO2005041931A3 (fr) 2006-04-06
US20050136009A1 (en) 2005-06-23
EP1684717A2 (fr) 2006-08-02
NO20062279L (no) 2006-05-19
CN1870976A (zh) 2006-11-29
JP2007509147A (ja) 2007-04-12
AU2004285447A1 (en) 2005-05-12
MXPA06004331A (es) 2006-06-05
BRPI0415707A (pt) 2006-12-19
WO2005041931A2 (fr) 2005-05-12
KR20060106823A (ko) 2006-10-12
ZA200603121B (en) 2007-09-26
CA2542530A1 (fr) 2005-05-12

Similar Documents

Publication Publication Date Title
GB2389530B (en) Pharmaceutical compositions
GB0320382D0 (en) Pharmaceutical compositions
GB0327723D0 (en) Pharmaceutical compositions
IL175973A0 (en) Pharmaceutical compositions comprising lercanidipine
IL171912A0 (en) Containers for pharmaceutical compositions
ZA200605080B (en) Pharmaceutical compositions
GB2391473B (en) Pharmaceutical compositions
HU0301154D0 (en) Pharmaceutical composition
GB0300531D0 (en) Pharmaceutical compositions
GB0300427D0 (en) Pharmaceutical composition
HK1084670A1 (en) Pharmaceutical compositions comprising cabbinochreme type compounds
EP1648411A4 (fr) Compositions pharmaceutiques
GB0307866D0 (en) Pharmaceutical composition
EP1699458A4 (fr) Composition pharmaceutique
GB0329232D0 (en) Pharmaceutical composition
GB0317663D0 (en) Pharmaceutical composition
PL378011A1 (pl) Proszkowe kompozycje farmaceutyczne
GB0213481D0 (en) Pharmaceutical compositions
EP1655029A4 (fr) Compositions medicinales
GB0300885D0 (en) Pharmaceutical composition
EP1480649A4 (fr) Compositions pharmaceutiques stables
SG147453A1 (en) Pharmaceutical aerosol compositions
EP1585530A4 (fr) Compositions pharmaceutiques bioadhesives
GB0306933D0 (en) Pharmaceutical composition
GB0305579D0 (en) Pharmaceutical compositions